Who Paid My Doc
Michael Mirro
Cardiovascular Disease Fort Wayne, IN Medical Doctor
NPI 1053303222 CMS profile 274851
11108 Parkview Circle Dr, Fort Wayne, IN 46845
General payments
$56,786
Research payments
$0
Ownership & investment interest
$36,605
Research they led as principal investigator
$85,383
Through program year 2023, Michael Mirro of Fort Wayne, IN is reported in the CMS Open Payments database as having received $56,786 across 26 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $85,383 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $36,605 across 3 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 94th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $65 | 2 | |
| 2022 | General | $24 | 1 | |
| 2021 | General | $2,500 | 1 | |
| 2020 | General | $88 | 1 | |
| 2019 | General | $54,110 | 21 | |
| 2025 | Ownership | $400 | 1 | |
| 2024 | Ownership | $205 | 1 | |
| 2021 | Ownership | $36,000 | 1 |
Beside peers
- Michael Mirro
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Michael Mirro were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Michael Mirro | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $54,110 | $450 | $127–$1,392 | $163 |
| 2020 | $88 | $242 | $77–$751 | $114 |
| 2021 | $2,500 | $335 | $101–$1,037 | $132 |
| 2022 | $24 | $395 | $121–$1,211 | $149 |
| 2023 | $65 | $443 | $136–$1,283 | $160 |
| 2024 | $0 | $450 | $136–$1,323 | $164 |
| 2025 | $0 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
26 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Indiana
John Miller
Cardiovascular Disease · Indianapolis, IN
David Kovacich
Cardiovascular Disease · Indianapolis, IN
Wai Lee
Cardiovascular Disease · Elkhart, IN
Anas Safadi
Cardiovascular Disease · Hobart, IN
Lawrence Rink
Cardiovascular Disease · Bloomington, IN
Vijay Rao
Cardiovascular Disease · Indianapolis, IN
Related records
Cardiovascular Disease in Indiana
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Indiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.